Copyright
©The Author(s) 1998.
World J Gastroenterol. Oct 15, 1998; 4(5): 388-391
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.388
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.388
Figure 2 Inhibition of luciferase gene expression by the toxin gene cotransfection.
A: Transfection with pGL2-Control only; B: Cotransfection with pGL2-Control and G1CEAPEANa; C: Cotransfection with pGL2-control and G1CEADTANa; D: Cotransfection with pGL2-control and pLNCPEA; E: Cotransfection with pGL2-control and pLNCDTA.
- Citation: Cao GW, Qi ZT, Pan X, Zhang XQ, Miao XH, Feng Y, Lu XH, Shigeki K, Ping D. Gene therapy for human colorectal carcinoma using human CEA promoter controled bacterial ADP-ribosylating toxin genes: PEA and DTA gene transfer. World J Gastroenterol 1998; 4(5): 388-391
- URL: https://www.wjgnet.com/1007-9327/full/v4/i5/388.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.i5.388